4th Quarter - Report

STEVE AUSTRIA AND ASSOCIATES, LLC for INNOVATIVE STERILIZATION TECHNOLOGIES

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

FDA safety standards

LobbyistCovered position, as disclosed
STEVE AUSTRIA US Congress (2009-2013)

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.